Akso Health Group ADR (AHG)

NASD · Healthcare · Medical Distribution · China

Akso Health Group ADR is a small cap company (market value between $300 million and $2 billion) in the Medical Distribution industry.

Intrinsic value, DCF valuation, financial health and value investing analysis for the Akso Health Group ADR stock.

Our verdict on AHG

Overvalued: intrinsic value $0.21 per share, market price $1.26, margin of safety -495.1% (as of 2026-10-30).

Its liquidation floor, current assets minus every liability, values the shares at $0.21; the price of $1.26 is 495% above that value.

Leak Score: 33/100 on 8 of 12 signals (On Watch).

Browse

Peers in Medical Distribution

All 11 Medical Distribution stocks

Compare side by side

Cheaper than AHG in Medical Distribution

Is AHG undervalued or overvalued?

AHG is overvalued (as of the 2026-10-30 close). Its liquidation floor, current assets minus every liability, values the shares at $0.21; the price of $1.26 is 495% above that value.

What is the intrinsic value of AHG?

$0.21 per share (as of the 2026-10-30 close), against a market price of $1.26. That is a margin of safety of -495.1%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.

What is Akso Health Group ADR's Leak Score?

33 out of 100, which we rate "On Watch", on 8 of 12 value investing signals.